Cytomx Therapeutics, Inc.

CTMX

Financials

10-QQ2 ended 06/30/2608/06/26 10-QQ1 ended 03/31/2605/07/26 10-KFY 202503/16/26 10-QQ3 ended 09/30/2511/06/25 10-QQ2 ended 06/30/2508/07/25

Disclosures

8-KCurrent report08/06/26 8-KCurrent report07/27/26 8-KCurrent report06/22/26 8-KCurrent report06/03/26 8-KCurrent report05/07/26

Prospectuses and Registrations

S-8Registration of securities for employees08/06/26 424B5Prospectus supplement03/18/26 424B5Prospectus supplement03/16/26 S-3ASRAutomatic shelf registration03/16/26 S-3Shelf registration08/07/25

Proxies

DEF 14ADefinitive proxy04/30/26 DEFA14AAdditional proxy materials04/30/26 PRE 14APreliminary proxy04/20/26 DEF 14ADefinitive proxy04/28/25 DEFA14AAdditional proxy materials04/28/25

Ownership

SC 13G/ABeneficial ownership (amended)10/28/26 4/AInsider transaction (amended)10/16/26 SC 13G/ABeneficial ownership (amended)08/14/26 SC 13G/ABeneficial ownership (amended)08/14/26 Form 3Initial insider ownership08/05/26

Other

EFFECTRequest for effectiveness08/18/25 CORRESPCorrespondence with the SEC08/14/25 UPLOADLetter from the SEC08/13/25 EFFECTRequest for effectiveness08/19/24 CORRESPCorrespondence with the SEC08/15/24